Resources

Subcutaneous DMPA (DMPA-SC) is an innovative injectable contraceptive that can dramatically expand access and choice for women. The Injectables Access Collaborative (AC) provides data-driven technical assistance, coordination, resources, and tools to ensure that women and girls have increased access to DMPA-SC and self-injection as part of an expanded range of contraceptive methods, delivered through informed choice programming. The Access Collaborative is led by PATH in partnership with the Clinton Health Access Initiative (CHAI), inSupply Health, Jhpiego, and JSI. For more information, visit the DMPA-SC Resource Library, Injectables Access Collaborative page, or email FPoptions@path.org.

In October 2023, Kenya witnessed an unprecedented political moment and a sign of commitment towards achieving Universal Health Coverage (UHC), when President William Ruto signed into law a series of bills aimed at strengthening the legal basis for health financing and health service provision through strong primary health care systems.These include:The Primary Health Care Act, 2023The Social Health Insurance Act, 2023The Facility Improvement Financing Act, 2023The Digital Health Act, 2023These laws are aimed at reducing disparities in health outcomes and promoting a healthier society by ensuring that all citizens have access to essential health care services in an equitable manner, regardless of their socioeconomic status, gender, ethnicity, or geographical location.This brief provides a summary of the key provisions of these laws, shining a light on commitments by government to improving health policy and financing environment to deliver health for all.

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools have achieved licensure that could help change that.The opportunity to address this pervasive virus has never been better. To raise awareness, PATH and the World Health Organization are developing an evolving toolkit of communication materials that public health stakeholders and advocates can use to share information about RSV disease, new prevention tools, and delivery considerations. Other expert contributors include the US Centers for Disease Control and Prevention, Seattle Children's Hospital/University of Washington, UMC Utrecht, RRD Design, and more.To accommodate varying audience and engagement needs, this toolkit includes a stand-alone RSV primer presentation (and fact sheet) providing an overview of RSV disease and prevention options. Also available are modular PowerPoint slides that can be mixed and matched with the primer presentation to dive deeper into key topics for informing understanding and decision-making around RSV prevention. All slides come with speaker notes.To learn more about the toolkit, visit the web page.Editable files are available upon request. Please contact us.

The Pandemic Fund—hosted by the World Bank—was created in September 2022 to provide a dedicated stream of additional, long-term funding for critical pandemic prevention, preparedness, and response (PPPR) in eligible low- and middle-income countries.According to expert forecasts, there is a 66 percent chance of another COVID-like respiratory pandemic with a death toll of more than 10 million in the next 25 years. To prepare, countries must strengthen their health systems to identify, diagnose, and treat respiratory infections.Tools like pulse oximeters, which detect hypoxemia (low oxygen saturation in the blood), can provide critical data that a respiratory pandemic is emerging, and medical oxygen and related therapies are essential to treatment as the recent COVID-19 pandemic demonstrated. An adequate supply of clinical and biomedical engineers, and technicians trained to operate and maintain both is a critical plank of PPPR.This factsheet outlines key information and resources for pursuing funding for medical oxygen and pulse oximetry through the Pandemic Fund. It is intended for use by beneficiaries, partners, civil society, and others, in developing funding requests and/or advocating for prioritizing medical oxygen and pulse oximetry in future Pandemic Fund proposals.

Africa’s pharmaceutical industry has undergone tremendous growth in all sectors over the years. This growth can be attributed to improvements in infrastructure, health care capacity, and business environment.The COVID-19 pandemic, however, brought to light the critical need for a more structured, robust, and resilient manufacturing sector for the continent. The industry was pushed by crisis to pick up the pace at establishing harmony within its different sectors, ensuring that they largely serve communities within Africa, and reduce over-reliance on pharmaceutical imports.This crisis also prompted increased political support for local medical products manufacturing, leading to a substantial expansion of African pharmaceutical manufacturing.